Dr Tammy Clifford

Agency:

CADTH

Job Title:

Vice-President, HTA

Organisation:

Canadian Agency for Drugs and Technologies in Health

Tel:

613 226 2553 x 1282

Fax:

613 226 5392

Email:

tammyc@cadth.ca

Website:

http://www.cadth.ca

Address:

865 Carling Avenue, Suite 600, Ottawa, Ontario, Canada, K1S 5S8

Agency Member Since:

26/5/1998

EAAS Name:

Horizon Scanning Programme

EAAS Host Organisation:

Canadian Agency for Drugs and Technologies in Health

Country and/or Region:

Canada

Year EAAS formally established:

1997

EAAS Status:

Permanent

EAAS Main Output Language:

English and French

EAAS Description:

The horizon scanning service alerts decision makers to new and emerging health technologies that are likely to have a significant impact on the delivery of health care in Canada. Horizon scanning also involves taking a more comprehensive look at the health care environment and maintaining a pulse on how evidence is being used to inform practice and policy decisions. Through our active, ongoing literature scanning, we identify health technologies that are in the early development or adoption phase, and which may affect health care finances, facilities, operations, and patient care. The service, which began in 1997, helps all Canadian jurisdictions monitor and stay abreast of rapid advances in health technology development.

Main source of funding:

Other: Canadian federal, provincial and territorial governments

Purpose of EAAS:

• To inform decisions on coverage or reimbursement of health services
• To inform decisions on captical or recurrent spending
• To inform decisions on undertaking primary research
• To inform decisions on undertaking secondary research (health technology assessments, systematic reviews)

Types of technologies covered by EAAS:

• Pharmaceuticals (including vaccines)
• Devices (including imaging equipment)
• Diagnostics (diagnostic and prognostic biomarkers)
• Interventional procedures (e.g. surgery)
• Programmes (e.g. screening and vaccination programmes)

Main customers of EAAS:

• National Government Health Departments & Ministers
• Regional, State or Provincial Government
• Health services purchasers, commissioners or other decision makers
• Health care providers e.g. hospitals
• Health care professionals, medical advisors or clinical experts

Contents of Main Output from EAAS:

• Potential for significant health service impact
• Safety and efficacy
• Assessment of clinical effectiveness